Skip to Content
While pandemic takes… image

While pandemic takes top priority for Biden, experts see favorable landscape for drug pricing action in Washington


Eric Sagonowsky, featuring Rachel Sachs (Former Academic Fellow)
Fierce Pharma

Politicians of all stripes have run on promises to lower drug prices over the years, and outgoing President Donald Trump was no different. Fast-forward four years—past several attempts…

Column: Trump utterly… image

Column: Trump utterly failed to cut drug prices. Here’s how Biden could do better.


Michael Hiltzik, featuring Rachel Sachs (Former Academic Fellow)
Los Angeles Times

As a sort of sour welcome for the Biden administration and a final slap in the face for Donald Trump, America’s drug companies jacked up prices on hundreds…

Trump admin enlists… image

Trump admin enlists private firm to review some Covid-19 tests


David Lim, featuring Rachel Sachs (Former Academic Fellow)
Politico

The Department of Health and Human Services is paying a private firm to review the accuracy of some Covid-19 tests — the latest example of the department’s political…

Rachel Sachs on… image

Rachel Sachs on COVID-19 EUAs, Trump’s last-minute drug pricing rules, & 2021 policy


featuring Rachel Sachs (Former Academic Fellow)
The UAEM Podcast

Rachel Sachs, an associate professor of Law at Washington University in St. Louis, discusses with Klara the issued Emergency Use Authorizations (EUAs) on COVID-19 therapeutics and vaccines, President Trump's…

Potential jurors favor… image

Potential jurors favor use of artificial intelligence in precision medicine


Alexander Stremitzer, featuring I. Glenn Cohen (Faculty Director)
EurekAlert!

Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the…

Trump leaves behind… image

Trump leaves behind largely unworkable drug-pricing policies


Erin Durkin, featuring Rachel Sachs (Former Academic Fellow)
National Journal

Between legal challenges and practical implementation problems, President Trump isn’t leaving much policy for the Biden team to work with. But he did shift the drug-policy conversation.

WCM-Q explores legal… image

WCM-Q explores legal issues of telemedicine in pandemic


featuring I. Glenn Cohen (Faculty Director)
The Peninsula

Doha: The legal implications of the dramatic rise in the use of telemedicine during the global COVID-19 pandemic were discussed at the latest installment of Weill Cornell Medicine-Qatar’s …

Now That COVID-19… image

Now That COVID-19 Vaccines Are Here, So Is the Prospect of Digital Immunity Passports


Jane C. Hu, featuring Carmel Shachar (Executive Director)
Slate

This week, the first doses of the Pfizer COVID-19 vaccine were administered in the U.S. With the FDA expected to approve Moderna’s vaccine imminently, people are already…

'Immunity… image

‘Immunity passports’ are already here. But they come with warnings.


Scott McLean and Florence Davey-Attlee, featuring Carmel Shachar (Executive Director)
CNN

With miles of barbed wire and electric fencing along its border and open government hostility to migrants, Hungary's borders aren't always the friendliest place for foreigners. That's…

Prospects Dim for… image

Prospects Dim for Medicare Drug Reimbursement Cuts


M. Alexander Otto, featuring Rachel Sachs (Former Academic Fellow)
Medscape

A proposal to lower Medicare Part B reimbursements for 50 physician-administered drugs and biologics to what drug manufacturers receive for them in other wealthy nations seems unlikely to take effect as…